RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.
1985 Agnelli, Giancarlo; Buchanan, Mr; Fernandez, F; Boneu, B; Van Ryn, J; Hirsh, J; Collen, D.
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery.
2007 Eriksson, Bi; Turpie, Ag; Lassen, Mr; Prins, Mh; Agnelli, Giancarlo; Kälebo, P; Gaillard, Ml; Meems, L; ONYX study, Group
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
2008 Buller, Hr; Lensing, Aw; Prins, Mh; Agnelli, Giancarlo; Cohen, A; Gallus, As; Misselwitz, F; Raskob, G; Schellong, S; Segers, A; Einstein DVT Dose Ranging Study, Investigators
A hybrid plasminogen activator binds to the u-PA receptor and has a reduced thrombolytic potency in vivo.
1993 Asselbergs, Fa; Bürgi, R; Hamerman, J; Heim, J; van Oostrum, J; Agnelli, Giancarlo
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.
2012 Verso, Melina; Agnelli, Giancarlo; Barni, S; Gasparini, G; Labianca, R.
A new strategy for anticoagulation: The factor XI inhibitors
2023 Vedovati, Maria Cristina; Becattini, Cecilia; Agnelli, Giancarlo
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement.
2007 Agnelli, Giancarlo; Haas, S; Ginsberg, Js; Krueger, Ka; Dmitrienko, A; Brandt, Jt
A prospective study on cardiovascular events after acute pulmonary embolism
2005 Becattini, Cecilia; Agnelli, Giancarlo; Prandoni, P.; Taliani, M.; Silingardi, M.; Salvi, R.; Poggio, R.; Imberti, D.; Pogliani, E.; Porro, F.; Casazza, F.; Ageno, W.
A prospective study on survival in cancer patients with and without venous thromboembolism.
2014 Agnelli, Giancarlo; Verso, Melina; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino', Lucio; Labianca, R.
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture.
1992 Agnelli, Giancarlo; Cosmi, B; Di Filippo, P; Ranucci, V; Veschi, F; Longetti, M; Renga, C; Barzi, F; Gianese, F; Lupattelli, Luciano
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. | 1985 | Agnelli, Giancarlo; Buchanan, Mr; Fernandez, F; Boneu, B; Van Ryn, J; Hirsh, J; Collen, D. | |
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery. | 2007 | Eriksson, Bi; Turpie, Ag; Lassen, Mr; Prins, Mh; Agnelli, Giancarlo; Kälebo, P; Gaillard, Ml; Meems, L; ONYX study, Group | |
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. | 2008 | Buller, Hr; Lensing, Aw; Prins, Mh; Agnelli, Giancarlo; Cohen, A; Gallus, As; Misselwitz, F; Raskob, G; Schellong, S; Segers, A; Einstein DVT Dose Ranging Study, Investigators | |
A hybrid plasminogen activator binds to the u-PA receptor and has a reduced thrombolytic potency in vivo. | 1993 | Asselbergs, Fa; Bürgi, R; Hamerman, J; Heim, J; van Oostrum, J; Agnelli, Giancarlo | |
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. | 2012 | Verso, Melina; Agnelli, Giancarlo; Barni, S; Gasparini, G; Labianca, R. | |
A new strategy for anticoagulation: The factor XI inhibitors | 2023 | Vedovati, Maria Cristina; Becattini, Cecilia; Agnelli, Giancarlo | |
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement. | 2007 | Agnelli, Giancarlo; Haas, S; Ginsberg, Js; Krueger, Ka; Dmitrienko, A; Brandt, Jt | |
A prospective study on cardiovascular events after acute pulmonary embolism | 2005 | Becattini, Cecilia; Agnelli, Giancarlo; Prandoni, P.; Taliani, M.; Silingardi, M.; Salvi, R.; Poggio, R.; Imberti, D.; Pogliani, E.; Porro, F.; Casazza, F.; Ageno, W. | |
A prospective study on survival in cancer patients with and without venous thromboembolism. | 2014 | Agnelli, Giancarlo; Verso, Melina; Mandalà, M; Gallus, S; Cimminiello, C; Apolone, G; Di Minno, G; Maiello, E; Prandoni, P; Santoro, A; Crino', Lucio; Labianca, R. | |
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. | 1992 | Agnelli, Giancarlo; Cosmi, B; Di Filippo, P; Ranucci, V; Veschi, F; Longetti, M; Renga, C; Barzi, F; Gianese, F; Lupattelli, Luciano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 540
- 1 Contributo su Rivista::1.1 Arti... 540
Data di pubblicazione
- 2020 - 2023 36
- 2010 - 2019 229
- 2000 - 2009 174
- 1990 - 1999 63
- 1980 - 1989 35
- 1977 - 1979 3
Editore
- F K Schattauer Verlagsgesellschaf... 3
- Roma : CEPI 3
- Elsevier Science Limited:Oxford F... 2
- ACP ASIM / American College of Ph... 1
- Blackwell Science Limited:PO Box ... 1
- Elsevier BV:PO Box 211, 1000 AE A... 1
- International Society on Thrombos... 1
- Massachusetts Medical Society:860... 1
Rivista
- THROMBOSIS AND HAEMOSTASIS 52
- JOURNAL OF THROMBOSIS AND HAEMOST... 40
- THROMBOSIS RESEARCH 29
- INTERNAL AND EMERGENCY MEDICINE 19
- HAEMATOLOGICA 17
- CHEST 16
- THE NEW ENGLAND JOURNAL OF MEDICINE 16
- EUROPEAN HEART JOURNAL 14
- CEREBROVASCULAR DISEASES 12
- EUROPEAN JOURNAL OF INTERNAL MEDI... 12
Keyword
- Humans 70
- Anticoagulants 59
- Female 44
- Male 44
- Cardiology and Cardiovascular Med... 39
- Aged 38
- Venous thromboembolism 37
- Medicine (all) 34
- Venous Thromboembolism 30
- Middle Aged 29
Lingua
- eng 519
- ita 12
- fre 1
- spa 1
Accesso al fulltext
- no fulltext 538
- open 2